Netherlands - Sold Production of Hormones, Prostaglandins, Thromboxanes and Leukotrienes
In 2017, the country was number 6 among other countries in Sold Production of Hormones, Prostaglandins, Thromboxanes and Leukotrienes at €184,402,000. Netherlands is overtaken by Germany, which was number 5 at €214,381,199.77 and is followed by France at €173,692,240.95. Sweden lead the ranking with €615,405,477 in 2018, -2.6% versus 2017. Italy, Ireland and Denmark respectively ranked number 2, 3 and 4 in this ranking. Spain witnessed the best average annual growth at +7.8% per year, while Germany was the worst growing country at -8.2% per year.
Loading...
| Date | Euros |
|---|---|
| 2017 | 184,402,000.00 |
| 2016 | |
| 2015 | |
| 2014 | |
| 2013 |
Download all data from 1995 to 2017
How does Netherlands rank in Sold Production of Hormones, Prostaglandins, Thromboxanes and Leukotrienes?
| # | 11 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Sweden
|
615,405,477.00 | 2018 | -2.6 % | NA | View data | |
| 2 |
#2
Italy
|
347,171,009.18 | 2019 | +4.6 % | +2.4 % | View data | |
| 5 |
#5
Germany
|
214,381,199.77 | 2019 | +0.0 % | -8.2 % | View data | |
| 6 |
#6
Netherlands
|
184,402,000.00 | 2017 | NA | NA | View data | |
| 7 |
#7
France
|
173,692,240.95 | 2019 | -0.7 % | +0.7 % | View data | |